The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines. - Tulaeva I; Lehmann F; Goldmann N; Dubovets A; Trifonova D; Tulaev M; Cornelius C; Weber M; Focke-Tejkl M; Karaulov A; Henning R; Springer DN; et al. (Vaccines, 2024)